Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Bio Key International (BKYI) Debt to Equity (2019 - 2025)

Bio Key International's Debt to Equity history spans 11 years, with the latest figure at $0.18 for Q3 2025.

  • For Q3 2025, Debt to Equity fell 89.39% year-over-year to $0.18; the TTM value through Sep 2025 reached $0.18, down 89.39%, while the annual FY2024 figure was $0.04, 80.18% down from the prior year.
  • Debt to Equity for Q3 2025 was $0.18 at Bio Key International, up from $0.07 in the prior quarter.
  • Across five years, Debt to Equity topped out at $1.7 in Q3 2024 and bottomed at -$2.01 in Q2 2024.
  • The 4-year median for Debt to Equity is $0.07 (2022), against an average of $0.07.
  • The largest YoY upside for Debt to Equity was 385.83% in 2023 against a maximum downside of 1101.64% in 2023.
  • A 4-year view of Debt to Equity shows it stood at $0.55 in 2022, then tumbled by 67.81% to $0.18 in 2023, then crashed by 80.18% to $0.04 in 2024, then soared by 411.54% to $0.18 in 2025.
  • Per Business Quant, the three most recent readings for BKYI's Debt to Equity are $0.18 (Q3 2025), $0.07 (Q2 2025), and $0.02 (Q1 2025).